Highlights
LSE: VAL       VALIRX PLC ORD 0.1P
Last Price Today's Change   Day's Range   Trading Volume
0.13   0.00 (0.00%)  0.127 - 0.134  11,918,408

Overview

 
Avg Volume (4 weeks):12,656,636
4 Weeks Range:0.12 - 0.141
4 Weeks Price Volatility (%):
47.62%
52 Weeks Range:0.12 - 1.48
52 Weeks Price Volatility (%):
0.74%
Average Price Target: 1.66
Price Target Upside/Downside: +1.53

Headlines



No recent Headlines for this stock.


Business Background

ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. It operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.

  Be the first to like this.
 


 

2063  2119  703  3405 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 WINZL 67.12-0.96 
 TRX 1.125+0.35 
 IPOST 390.75-4.60 
 VAST 0.395-0.015 
 EUZ 0.028+0.002 
 BOU 0.024+0.001 
 PREM 0.138-0.002 
 SNT 0.16-0.055 
 INSP 0.063+0.028 
 SD12 0.020.00 
Partners & Brokers